According to a market report by Lucintel, the future of the global homozygous familial hypercholesterolemia market looks promising with opportunities in the hospital, retail pharmacy, and online pharmacy markets. The global homozygous familial hypercholesterolemia market is expected to grow with a CAGR of 2.3% from 2024 to 2030. The major drivers for this market are increasing rates of cardiovascular diseases, rising number of clinical trials, as well as, growing use of CRISPR-Cas9 in the treatment of homozygous familial hypercholesterolemia.
A more than 150-page report to understand trends, opportunity and forecast in homozygous familial hypercholesterolemia market to 2030 by drug class (statins, cholesterol absorption inhibitors, PCSK9 inhibitors, MTP inhibitors, and ANGPTL3 inhibitors), route of administration (oral, parenteral, and nasal), technology (CRISPR-Cas9, RNA interference, and nanoparticle-based therapies), distribution channel (hospitals, retail pharmacies, and online pharmacies), and region (North America, Europe, Asia Pacific, and the Rest of the World).
Lucintel forecasts that, within the drug class category, statin will remain the largest segment over the forecast period due to its efficaciousness in lowering LDL cholesterol and controlling cardiovascular risk.
Within the distribution channel, hospital is expected to witness the highest growth.
Download sample by clicking on homozygous familial hypercholesterolemia market
In terms of region, North America will remain the largest region over the forecast period due to the region high level of research activity along with technological advancements made by significant organizations, presence of a large number of important actors who have settled there, and the rising incidence of atherosclerotic cardiovascular disease (ASCVD).
AstraZeneca, Viatris, Teva Pharmaceutical Industries, Accord Healthcare, Changzhou Pharmaceutical Factory, Regeneron Pharmaceuticals, Amryt Pharma are the major suppliers in the homozygous familial hypercholesterolemia market.
This unique research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or write us at [email protected] To get access of more than 1000 reports at fraction of cost visit Lucintel's Analytics Dashboard.
About Lucintel
At Lucintel, we offer solutions for you growth through game changer ideas and robust market & unmet needs analysis. We are based in Dallas, TX and have been a trusted advisor for 1,000+ clients for over 20 years. We are quoted in several publications like the Wall Street Journal, ZACKS, and the Financial Times.
Contact:
Roy Almaguer
Lucintel
Dallas, Texas, USA
Email: [email protected]
Tel. +1-972-636-5056
Explore Our Latest Publications
Self-Adhesive Label Market
Synthetic Magnetite Market
Ultra-Low Phase Noise RF Signal Generator Market
Biofilm Treatment Market
Colorectal Cancer Diagnostic Market
Viral Vector Manufacturing Market